Six critical metabolic enzymes within four pathways were present at higher levels in tumor compartments than in normal tissue: the pyrroline-5-carboxylate reductase PYCR2, glutaminase, uridine phosphorylase UPase1, fatty acid synthase, and ornithine decarboxylase. The gene discussed is PYCR2; the disease is neoplasm.